Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

5589 ARTÍCULOS , VIENDO DEL 2551 AL 2565

Genome Editing in iPSC-Based Neural Systems: From Disease Models to Future Therapeutic Strategies

McTague A, Rossignoli G, Ferrini A, Barral S, Kurian MA.

Front Genome Ed. 2021 Mar 15;3:630600. doi: 10.3389/fgeed.2021.630600. eCollection 2021.

The initial diagnosis and management of Parkinson's disease

Waller S, Williams L, Morales-Briceño H, Fung VS.

Aust J Gen Pract. 2021 Nov;50(11):793-800. doi: 10.31128/AJGP-07-21-6087.

[Deep brain stimulation of the subthalamic nucleus for parkinson's disease: awake vs asleep]

Asriyants SV, Tomskiy AA, Gamaleya AA, Pronin IN.

Zh Vopr Neirokhir Im N N Burdenko. 2021;85(5):117-121. doi: 10.17116/neiro202185051117.

Structure-function similarities in deep brain stimulation targets cross-species

Keuken MC, Alkemade A, Stevenson N, Innes RJ, Forstmann BU.

Neurosci Biobehav Rev. 2021 Dec;131:1127-1135. doi: 10.1016/j.neubiorev.2021.10.029. Epub 2021 Oct 26.

Sense of agency disturbances in movement disorders: A comprehensive review

Seghezzi S, Convertino L, Zapparoli L.

Conscious Cogn. 2021 Nov;96:103228. doi: 10.1016/j.concog.2021.103228. Epub 2021 Oct 27.

Zonisamide improves wearing off in Parkinson's disease without exacerbating dyskinesia: Post hoc analysis of phase 2 and phase 3 clinical trials

Tsuboi Y, Nakamura M, Maruyama H, Matsumoto Y.

J Neurol Sci. 2021 Nov 15;430:120026. doi: 10.1016/j.jns.2021.120026. Epub 2021 Oct 7.

Cholinesterase inhibitor to prevent falls in Parkinson's disease (CHIEF-PD) trial: a phase 3 randomised, double-blind placebo-controlled trial of rivastigmine to prevent falls in Parkinson's disease

Neumann S, Taylor J, Bamford A, Metcalfe C, Gaunt DM, Whone A, Steeds D, Emmett SR, Hollingworth W, Ben-Shlomo Y, Henderson EJ.

BMC Neurol. 2021 Oct 29;21(1):422. doi: 10.1186/s12883-021-02430-2.

Neuroprotective effects of oleuropein: Recent developments and contemporary research

Butt MS, Tariq U, Iahtisham-Ul-Haq, Naz A, Rizwan M.

J Food Biochem. 2021 Dec;45(12):e13967. doi: 10.1111/jfbc.13967. Epub 2021 Oct 30.

The case of a 29-year-old man with psychiatric illness and parkinsonism

Larson D.

Ann Clin Transl Neurol. 2021 Nov;8(11):2210. doi: 10.1002/acn3.51474. Epub 2021 Oct 30.

Psychiatric Comorbidities in Parkinson's Disease Seen through the Prism of Genomics and Epigenetics

Blažeković A, Borovečki F.

Psychiatr Danub. 2021 Spring-Summer;33(Suppl 4):456-462.

Optimizing Cognitive Training for the Treatment of Cognitive Dysfunction in Parkinson's Disease: Current Limitations and Future Directions

Guglietti B, Hobbs D, Collins-Praino LE.

Front Aging Neurosci. 2021 Oct 13;13:709484. doi: 10.3389/fnagi.2021.709484. eCollection 2021.

Dance Is an Accessible Physical Activity for People with Parkinson's Disease

Emmanouilidis S, Hackney ME, Slade SC, Heng H, Jazayeri D, Morris ME.

Parkinsons Dis. 2021 Oct 22;2021:7516504. doi: 10.1155/2021/7516504. eCollection 2021.

Parkinson's Disease Risk and Alcohol Intake: A Systematic Review and Dose-Response Meta-Analysis of Prospective Studies

Shao C, Wang X, Wang P, Tang H, He J, Wu N.

Front Nutr. 2021 Oct 14;8:709846. doi: 10.3389/fnut.2021.709846. eCollection 2021.

Case Report: Synucleinopathy Associated With Phalaris Neurotoxicity in Sheep

Tayebi M, Pinczowski P, Habiba U, Khan R, David MA, Summers BA.

Front Vet Sci. 2021 Oct 14;8:736567. doi: 10.3389/fvets.2021.736567. eCollection 2021.

Pain coping strategies and their association with quality of life in people with Parkinson's disease: A cross-sectional study

Prell T, Liebermann JD, Mendorf S, Lehmann T, Zipprich HM.

PLoS One. 2021 Nov 1;16(11):e0257966. doi: 10.1371/journal.pone.0257966. eCollection 2021.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias